A systematic review of the global prevalence and incidence of shoulder pain.

Epidemiology Global health Incidence Prevalence Primary care Shoulder pain

Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
08 Dec 2022
Historique:
received: 20 03 2022
accepted: 09 11 2022
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Studies reporting on the population burden of people living with shoulder pain show wide heterogeneity in terms of case definition, study samples, and occurrence. This systematic review aims to summarize evidence pertaining to the prevalence and incidence of shoulder pain, including variability based on sex and geography. We also explored the potential influence of methodological limitations and important sources of heterogeneity (case definition and reference period) on reported estimates of shoulder pain prevalence. The study protocol was registered on Prospero under CRD42021243140. We searched EMBASE, CINAHL, Web of Science and Medline from inception to March 2021. Study selection, data extraction and risk of bias assessment was conducted by a team of three researchers. We performed a narrative synthesis of the data, using forest plots to summarize study findings, and stratified data presentation to explore the potential association of risk of bias, case definition, and reference period with estimates of prevalence and incidence of shoulder pain. We obtained data from 61 studies reporting data from high-, middle- and low-income countries. The overall risk of bias was low, with most rated as "low-risk" and no studies rated as "high-risk". The community prevalence of shoulder pain varied widely across the countries included in our review, with a median of 16% (range 0.67 to 55.2%). Longer reference periods were typically associated with higher prevalence estimates. Primary care prevalence ranged from 1.01 to 4.84% (median 2.36%). Estimates were generally higher for women than men and were higher in high-income nations. The incidence of shoulder pain ranged from 7.7 to 62 per 1000 persons per year (median 37.8 per 1000 persons per year). Risk of bias did not clearly explain variability in study findings, but there was considerable variation in study samples, methods used, and a relative absence of data from low-income countries. Our review demonstrates that a significant proportion of the population across the world will experience shoulder pain daily, yearly, and throughout a lifetime. Regional gaps in evidence and methodological inconsistencies must be addressed in order to establish a more definitive global burden.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Studies reporting on the population burden of people living with shoulder pain show wide heterogeneity in terms of case definition, study samples, and occurrence. This systematic review aims to summarize evidence pertaining to the prevalence and incidence of shoulder pain, including variability based on sex and geography. We also explored the potential influence of methodological limitations and important sources of heterogeneity (case definition and reference period) on reported estimates of shoulder pain prevalence.
DATABASES AND DATA TREATMENT METHODS
The study protocol was registered on Prospero under CRD42021243140. We searched EMBASE, CINAHL, Web of Science and Medline from inception to March 2021. Study selection, data extraction and risk of bias assessment was conducted by a team of three researchers. We performed a narrative synthesis of the data, using forest plots to summarize study findings, and stratified data presentation to explore the potential association of risk of bias, case definition, and reference period with estimates of prevalence and incidence of shoulder pain.
RESULTS RESULTS
We obtained data from 61 studies reporting data from high-, middle- and low-income countries. The overall risk of bias was low, with most rated as "low-risk" and no studies rated as "high-risk". The community prevalence of shoulder pain varied widely across the countries included in our review, with a median of 16% (range 0.67 to 55.2%). Longer reference periods were typically associated with higher prevalence estimates. Primary care prevalence ranged from 1.01 to 4.84% (median 2.36%). Estimates were generally higher for women than men and were higher in high-income nations. The incidence of shoulder pain ranged from 7.7 to 62 per 1000 persons per year (median 37.8 per 1000 persons per year). Risk of bias did not clearly explain variability in study findings, but there was considerable variation in study samples, methods used, and a relative absence of data from low-income countries.
CONCLUSIONS CONCLUSIONS
Our review demonstrates that a significant proportion of the population across the world will experience shoulder pain daily, yearly, and throughout a lifetime. Regional gaps in evidence and methodological inconsistencies must be addressed in order to establish a more definitive global burden.

Identifiants

pubmed: 36476476
doi: 10.1186/s12891-022-05973-8
pii: 10.1186/s12891-022-05973-8
pmc: PMC9730650
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073

Informations de copyright

© 2022. The Author(s).

Références

Pain. 2004 Jun;109(3):420-431
pubmed: 15157703
Ann Rheum Dis. 1998 Nov;57(11):649-55
pubmed: 9924205
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
Clin Exp Rheumatol. 2002 Sep-Oct;20(5):617-24
pubmed: 12412191
Scand J Rheumatol. 2004;33(2):73-81
pubmed: 15163107
Rheumatol Int. 2017 Apr;37(4):495-502
pubmed: 28168545
BMC Musculoskelet Disord. 2012 Feb 10;13:17
pubmed: 22325050
J Rheumatol Suppl. 2011 Jan;86:9-14
pubmed: 21196593
Clin Rheumatol. 2009 Nov;28(11):1267-74
pubmed: 19629618
J Rheumatol. 2008 Jul;35(7):1384
pubmed: 18464299
Res Synth Methods. 2021 Jan;12(1):55-61
pubmed: 32336025
J Shoulder Elbow Surg. 2017 May;26(5):766-773
pubmed: 28089260
Ann Saudi Med. 2005 Nov-Dec;25(6):459-62
pubmed: 16438453
Arch Physiother. 2021 Nov 4;11(1):24
pubmed: 34736540
J Clin Epidemiol. 2021 Sep;137:209-217
pubmed: 33933579
Knee Surg Sports Traumatol Arthrosc. 2018 Jan;26(1):188-194
pubmed: 28647843

Auteurs

J Lucas (J)

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, Staffordshire, UK. jonathan.lucas2@nhs.net.

P van Doorn (P)

Department of General Practice, Erasmus Medical Centre, Rotterdam, Netherlands.

E Hegedus (E)

Doctor of Physical Therapy Program, Tufts University School of Medicine, 101 E Washington Street, Suite 950, Phoenix, AZ, 85004, USA.

J Lewis (J)

Therapy Department, Central London Community Healthcare National Health Service Trust, London, UK.
Musculoskeletal Research, Clinical Therapies, University of Limerick, Limerick, Ireland.

D van der Windt (D)

Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Keele, Staffordshire, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH